Sonoma announces closing of $22 million Series D financing

Sonoma Orthopedic Products announced that it has closed a $22 million Series D financing round led by Ascension Health Ventures (AHV).  Also participating in the round were Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners.  In connection with the financing, Dr. Walter Lin of AHV has joined Sonoma's board of directors.

Sonoma is a commercial orthopedic trauma company focused on minimally invasive repair of fractured bone through its proprietary implant technology.  The financing will support several new product launches, expansion of the U.S. sales network, key clinical trials, and the acquisition of certain key assets of NovaLign Orthopaedics, Inc.  "We are pleased by the level of support provided by Sonoma's distinguished new and existing investors, who share our vision for advancing the field of minimally invasive fracture repair," said Glen Coleman, President and CEO of Sonoma Orthopedic Products.

AHV's Dr. Walter Lin added, "Sonoma's unique flexible-to-rigid WaviBody and TaperBody platform technologies address a clear clinical need in orthopedic trauma care.  We are excited to partner with Sonoma's experienced management team and board to make its implants more widely available for the benefit of patients."